ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia

Stroke

Volumn 29, Issue 7, 1998, Pages 1401-1404

  Chapman, Joab ^b   Wang, Ningshan ^b   Treves, Therese A ^b   Korczyn, Amos D ^b   Bornstein, Natan M ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Angiotensin converting enzymes; Apolipoprotein E; Dementia; Factor V Leiden; Methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E4; BLOOD CLOTTING FACTOR 5 LEIDEN; DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL;

EID: 0031836810     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.7.1401     Document Type: Article

References (39)

1. Amar K, Wilcock G. Vascular dementia. BMJ. 1996;312:227-231.
2. Roman G, Tatemaichi T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
3. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke. 1997;28:459-463.
4. Korczyn A. The clinical differential diagnosis of dementia: concept and methodology. Psychiatr Clin North Am. 1991;14:237-249.
5. Gold G, Giannakopoulos P, Montes-Paixao Junior C, Hermann FR, Mulligan R, Michel JP, Bouras C. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology. 1997;49:690-694.
6. Weiterung T, Kanitz RD, Brogis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke. 1996;27:30-36.
7. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
8. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke. 1995;26:1329-1333.
9. Catto A, Carter AM, Barrett JH, Stickland M, Bamford J, Davies JA, Grant PJ. Angiotensin-converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke. 1996;27:435-440.
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113. Letter.
11. Bertina R, Koeleman B, Koster T, Rosendaal F, Dirven R, de Ronde H, van der Velden P, Reitsma P. Mutations in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369: 64-67.
12. Greengard JS, Eichinger S, Griffin JH, Bauer KA. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg→Gln mutation in the gene for factor V. N Engl J Med. 1994;331:1559-1562.
13. Catto A, Carter A, Grant PJ. Factor V Leiden mutation and completed stroke. Stroke. 1996;27:573. Letter.
14. Morris BJ, Zee RY, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-1089.
15. Sharma P, Carter ND, Barley J, Brown MM. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens. 1994;8:645-648.
16. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation. 1996;93:1630-1633.
17. Boers GH, Smals AG, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PW. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709-715.
18. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 1995;56:142-150.
19. Kluitmans L, van den Heuvel L, Boers G, Frosst P, Stevens E, van Oost B, den Heijer M, Tribels FJ, Rozen R, Blom H. Molecular genetic analysis in mild hyperhomocyteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a risk factor for cardiovascular disease. Am J Hum Genet. 1996;58:35-41.
20. Ridker P, Hennekens C, Lindpaintner K, Stampfer M, Eisenberg P, Miletich J. Mutations in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-917.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
22. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
23. Chapman J, Estupinan J, Asherov A, Goldfarb LG. A simple and efficient method for apolipoprotein E genotype determination. Neurology. 1996; 46:1484-1485.
24. Schmidt S, van Hooft IM, Grobbee DE, Ganten D, Ritz, E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens. 1993;11:345-348.
25. Treves TA, Bornstein NM, Chapman J, Klimovitzki S, Verchovsky R, Asherov A, Veshchev IO, Korczyn AD. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 1996;10:189-191.
26. Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:737. Letter.
27. Sakoda S, Kuriyama M, Osame M, Takahashi K, Yamano T, Sasaki J, Matsunaga A. Apolipoprotein E epsilon 4. Neurology. 1994;44:2420, 2421. Letter.
28. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry. 1994;57:1414-1416.
29. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R. Apolipoprotein E epsilon4 and the risk of dementia with stroke: a population-based investigation. JAMA. 1997;277:818-821.
30. Arai H, Higuchi S, Sasaki H. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease. Gerontology. 1997;43(suppl 1):2-10.
31. Higuchi S, Arai H, Nakagawa T, Muramatsu T, Sasaki H, Trojanowski JQ. The apolipoprotein E gene in Binswanger's disease and vascular dementia. Clin Genet. 1996;50:459-461.
32. Cacabelos R, Rodriguez B, Carrera C, Caamano J, Beyer K, Lao JI, Sellers MA. APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol. 1996;18: 693-706.
33. Pirttila T, Lehtimaki T, Rinne J, Mattila K, Frey H, Nikkari T. The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand. 1996;93:352-354.
34. Sulkava R, Kainulainen K, Verkkoniemi A, Niinisto L, Sobel E, Davanipour Z, Polvikoski T, Haltia M, Kontula K. APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+. Neurobiol Aging. 1996;17:373-376.
35. Helisalmi S, Linnaranta K, Lehtovirta M, Mannermaa A, Heinonen O, Ryynanen M, Riekkinen P Sr, Soininen H. Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci Lett. 1996;205:61-64.
36. Isoe K, Urakami K, Sato K, Takahashi K. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand. 1996;93:133-137.
37. Scacchi R, De Bernardini L, Mantuano E, Donini LM, Vilardo T, Corbo RM. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett. 1995;201:231-234.
38. Mahieux F, Couderc R, Moulignier A, Bailleul S, Podrabinek N, Laudet J. Isoform 4 of apolipoprotein E. and Alzheimer disease: specificity and clinical study. Rev Neurol (Paris). 1995;151:231-239.
39. Grearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA, Heyman A. The Consortion to Establish a Registry for Alzheimer's Disease (CERAD), X: neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995:45(3 pt 1):461-466.